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Summ~ 
We found that c-kit-positive,  lineage marker-negative, Thy-11~ cells are present in both bone 
marrow and thymus ("BM c-kit"  and "thymus c-kit"  cells). Although the two cell types are 
phenotypically similar,  only BM c-hit cells showed the potential to form colonies in vitro as 
well as in vivo. However, both of them revealed extensive growth and differentiation potential 
to T cells after direct transfer into an irradiated adult thymus, or a deoxyguanosine-treated fetal 
thymus. Time course analysis  showed that  thymus c-kit  cells differentiated into CD4CD8 
double-positive cells approximately 4 d earlier than BM c-kit cells did. In addition, anti-c-kit 
antibody blocked T cell generation of BM c-kit cells but not of thymus c-kit cells. Intravenous 
injection of thymus c-kit resulted in the generation of not only T cells, but B as well as NKI.1 + 
cells. These data provide evidence that thymus c-kit cells represent common lymphoid progenitors 
with the differentiation potential to T, B, and possibly NK cells. The c-kit-mediated  signaling 
appears to be essential in the transition from BM c-kit to thymus c-kit cells. 
1  blood cells, including lymphocytes, originate from the 
hematopoietic stem cells located in bone marrow (1, 
2). With the exception of T lymphocytes that require special 
thymic environment for maturation and selection (3), most 
of hematopoiesis takes place in the bone marrow. The exis- 
tence of a sustained T  cell development in the thymus re- 
quires a continuous input of precursor cells from bone marrow 
(4, 5). However, we do not know whether bone marrow- 
derived pluripotent stem cells come to the thymus and differen- 
tiate there into mature T cells, or if they start differentiating 
in  the bone marrow  and  only immature,  T-committed, 
precursor cells migrate into the thymus for further differen- 
tiation. Earliest T cell precursors in the adult murine thymus 
have recently been identified within the CD41~ 
population (6). However, the sequence of differentiation events 
linking these precursor cells to the hematopoietic stem cell 
in the bone marrow is still unclear. 
We have recently developed a mAb that reacts with the 
murine c-kit receptor tyrosine kinase (7).  The injection of 
the mAb into adult mice resulted within 2 d in a marked 
decrease in the number of peripheral erythroid and myeloid 
cells (8). However, peripheral B cells were relatively increased 
in numbers and peripheral T cells and immature thymocytes 
remained unaffected by the treatment. Animals that received 
antibody treatment died of severe anemia before the effect 
on lymphoid cells became obvious. These findings suggested 
that the stem cells for the erythroid/myeloid  lineages behaved 
differently from stem cells for lymphoid cells in the effect 
of anti-c-kit reagent. When we sorted c-kit +  , Thy-1  l~ lin- 
eage marker negative cells (c-kit +,  Thy-1  l~  Lin-) using a 
FACS  |  (Becton Dickinson Immunocytometry Systems, San 
Jose, CA) in adult bone marrow, the population thus highly 
enriched in stem cells displayed a capacity to reconstitute in 
the long term, all hematopoietic lineages  including B and 
T lymphocytes (9). Thus, the relative ineffectiveness of the 
anti-c-kit antibody treatment most likely reflects distinctive 
features  of B and T  lymphocytes in vivo. 
To address the role of c-kit and of microenvironment in 
early lymphoid differentiation, we have attempted to estab- 
lish an in vitro culture system in which T cells can be gener- 
ated either from the bone marrow stem cells or from T-com- 
mitted progenitors. In the present study, we have identified 
and characterized  c-kit + Thy-11~ Lin-  cells from the adult 
thymus (thymus c-kit cells) and compared them with cells 
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c-kit cells). Our results indicate that both thymus c-kit and 
BM c-kit cells can differentiate into T cells in the thymic en- 
vironment and that thymus c-kit cells have lost the potential 
to differentiate into nonlymphoid cells. In addition, we show 
that, the generation ofT cells from BM c-kit cells is far more 
dependent on the c-kit-mediated  signaling than that from 
thymus c-kit  cells. 
Materials and Methods 
Mice.  For the donor ofthymocytes and bone marrow cells, con- 
genic  mice C57BL/6J-Ly5.1:Pep3  b (B6-Ly 5.1) were bred  and 
maintained in our animal facility. C57BL/6-N  (B6-Ly 5.2) mice 
were purchased from Clea Japan (Tokyo,  Japan) for the recipient 
of intra-thymic injection and spleen colony assay. Pregnant B6-Ly 
5.2 mice, the donor of fetal thymus were purchased from SIC Inc. 
(Hamamatsu, Japan) at day 9 of pregnancy. 
Antibodies.  For cell sorting, biotinylated rat mAbs, RA-6B2 
(anti-B220) (10), M1/70 (anti-Mac-I) (11), RA3-8C5 (anti-Gr-1) 
(12), GK1.5 (anti-L3T4) (13), 53-6.7 (anti-Ly 2) (14), and TER119 
(15) were used as lineage markers. FITC-labeled  30-H12 (anti-Thy- 
1.2) (16) and APC-conjugated ACK-2 (anti-c-kit) (7) were used as 
stem cell markers. B220, Mac-l, and GK1.5 were purified  by affinity 
chromatography on immobilized protein A and were derivatized 
with biotin by standard techniques (17). Ly 2-biotin and Thy-I.2- 
FITC were purchased from Becton Dickinson Immunocytometry 
Systems. Gr-l-biotin was purchased from Pharmingen (San Diego, 
CA).  TER119-biotin were obtained from Dr.  T.  Kina  (Kyoto 
University, Kyoto,  Japan). Rat anti-c-k/t  mAb was purified and con- 
jugated with APC by standard method (17). All biotinylated re- 
agents were visualized  by using Streptavidin-PE second step reagent 
(Becton Dickinson Immunocytometry Systems). 
For analysis  of reconstituted cells, mouse mAbs A20.1 (anti-Ly 
5.1) obtained from Dr. Yumiko Saga (RIKEN, Tsukuba, Japan) 
and 104.2 (anti-Ly 5.2) obtained from Dr. Hidetaka Yakura (Tokyo 
Metropolitan Institute for Neuroscience, Tokyo,  Japan) were deriva- 
tized with fluorescein or biotin, respectively. Rat anti-Ly 2 mAb 
was purified and labeled with allophycocyanin.  PE-labeled GK1.5 
was  purchased from  Becton Dickinson.  PE-labeled B220 and 
Gr-1 and Ly 2, and FITC-labeled Mac-l,  Gr-1, and anti-NKl.1 
(PK136) (18) were purchased from Pharmingen. 
Cell Preparation.  Thymus glands were surgically excised from 
4-6-wk-old female B6-Ly  5.1 mice. Thymus cell suspensions were 
prepared by pressing the tissue through a 100-gauge stainless steel 
mesh. Bone marrow cells were flushed from femurs with staining 
medium (PBS with 3% FCS and 0.1% sodium azide). The suspen- 
sions were filtered through a 200-gauge nylon mesh to remove 
debris. 
Staining with Antibodies.  4  x  10  s of thymocytes or 4  x  107 
of bone marrow cells were reacted with a cocktail of biotinylated 
rat mAbs specific  for mouse differentiation antigens Gr-1, Mac-l, 
B220, TER119, CD4, and CD8 (see above for antibody designa- 
tions) for 30 min at 4~  After washing the cells three times with 
staining medium,  thymocytes were incubated in culture dishes, 
coated with sheep anti-rat immunoglobulins, and bone marrow 
cells were treated with magnetic bead-conjugated sheep anti-rat 
immunoglobulin (Dynabeads,  Dynal, A.S., Oslo, Norway), for 30 
1 Abbreviations used in this pa1~er: BM, bone marrow; dGuo, Z'-deoxy 
guanosine; HPSC, hematopoietic  stem cells; PI, propidium iodide. 
min at 4~  to remove lineage marker high positive cells. Nonad- 
herent cells  were collected  and reacted  with Thy-I-FITC, c-kit-APC, 
and SAV-PE at 4~  for another 30 rain. After a second wash, the 
cells were resuspended  in staining medium at a final  concentration  of 
106 cells/ml supplemented with propidium iodide (PI, 1 gg/ml). 
FACS |  Analysis and Cell Sorting.  Stained  cells were analyzed  by 
FACStar  vlu~ (registered trademark of Becton Dickinson) equipped 
with a 488-nm argon laser  and a 599-nm dye laser. Data from 50,000 
cells were collected and analyzed. Computer-assisted data analysis 
of results was done on a MicroVAX computer (Digital Equipment 
Corp., Maynard, MA) with FACS/DESK software (version 1.8) 
made available through the FACS development group at Stanford 
University (Stanford, CA). After analysis,  c-kit + Thy-1  I~ Lin- cells 
were sorted. Residual erythrocytes, debris, doublets, and dead cells 
were excluded  by forward scatter, side  scatter, and PI gating. Fluores- 
cence intensity of individual cells was measured as relative fluores- 
cence units. 
Micro Intra-thymic  Injection.  Fetal  thymus organ cultures and 
micro injections were done as described  previously  (19, 20). Briefly, 
day 14 fetal thymic lobes from B6-Ly  5.2 mice were organ cultured 
on the surface of filters (0.8-mm pore size; Nucleopore Corpora- 
tion, Pleasanton, CA) in 3.5 mm petri dishes containing 3 ml of 
RPMI 1640 medium (Gibco Laboratories,  Grand Island, NY) sup- 
plemented with 10% FCS (Bioproducts, Inc., Walkersville,  MD), 
1.35 mM 2'-deoxy  guanosine  (dGuo; Sigma  Chemical  Co., St. Louis, 
MO), 100 U/ml penicillin, and 100 gg/ml streptomycin for 6 d 
at 37"C under 5% COz in air. Each thymic lobe was then washed 
with RPMI and injected with 500-1,000 of sorted c-kit + Thy-1  I~ 
Lin- cells from 4 to 6 wk-old female B6-Ly 5.1 mice by using a 
micro manipulator (Narishige, Tokyo,  Japan). After injection, the 
lobes were organ cultured for 8-24 d on the surface of 3 ml of 
10% FCS supplemented RPMI 1640 medium. The reconstituted 
thymocytes were stained with anti-Ly 5.1, CD4, and CD8, and 
analyzed by FACS  | 
Intra-thymic Injection.  Intra-thymic injections of sorted c-kit + 
Thy-1  l~ Lin- thymocytes or bone marrow calls were performed 
under nembutal anesthesia (21). 6-8-wk-old female  B6-Ly  5.2 mice 
were irradiated (6.5 Gy) within 6 h before surgery. 104 sorted kit + 
Thy-1  I~ Lin- thymocytes or bone marrow cells from 4-6-wk-old 
female B6-Ly 5.1 mice were injected into one thymic lobe of each 
recipient mouse in a volume of 5/zl. Mice were killed by neck dis- 
location at 8-24 d after injection and a cell suspension was pre- 
pared from each thymic lobes. The suspensions were stained and 
analyzed as described above. 
In Vitro Colony Assay (CFU-C and HPP-CFC).  Methylcellulose 
culturing was carried out using a modification of the technique 
described by Iscove et al. (22). 1 ml of culture medium contained 
an  adequate number  of  sorted  c-kit +  Thy-1  z~ Lin-  thymo- 
cytes or bone marrow cells, 1.2% methylcellulose  (Fisher  Scientific, 
Norcross, GA), or-medium (Flow Laboratories, North Ryde, Aus- 
tralia), 30% FCS (Flow Laboratories), 1% deionized BSA (Sigma 
Chemical Company), 0.1 mM 2-ME (Eastman Organic Chemical, 
Rochester, NY), and IL-3 (100 U/ml) and EPO (1 U/ml). In the 
case of  high proliferative  potential colony forming cell (HPP-CFC) 
assay, IL-1 (2 ng/ml), II,-3 (10 ng/ml), M-CSF (10 U/ml), GM- 
CSF (10 ng/ml), and stem cell factor (10 ng/ml) were added. The 
cultures were prepared in 35 mm nontissue culture dishes (Falcon 
Labware, Oxnard, CA) and incubated at 37~  in a humidified at- 
mosphere of 5% COz. The number of colonies was counted after 
14 d of culture using an inverted microscope. 
In  Vivo Colony Assay.  Spleen  colony assay was performed by 
using standard method (23). 10-14-wk-old B6-Ly 5.2 female mice 
were lethally irradiated at a dose of 9.5 Gy total body irradiation. 
1284  Function  of c-kit in Early T Cell Development Unfractionated  thymocytes or bone marrow cells,  sorted c-kit + 
Thy-1  l~ Lin-  thyrnocytes, or bone marrow cells were injected into 
the irradiated  mice intravenously from the retro-orbital plexus. After 
injection, the spleens were removed at day 10, fixed in Bouin's so- 
lution, and macroscopically visible spleen colonies were counted. 
Lineage  Reconstitution  Assay.  10,000  sorted thymus c-kit cells 
from B6-Ly 5.1 mice were injected into the sublethally irradiated 
B6-Ly 5.2 mice (8.7 Gy). 3 wk after injection, cells from the spleen 
and thymus were collected an  d stained in three colors with donor- 
specific anti-Ly 5.1 (biotinylated) and lineage-specific antibodies (ei- 
ther FITC-conjugated anti-Gr-1, Mac-l, or NKI.1 and either PE- 
conjugated anti-B220, GK 1.5, or Ly 2), followed by APC-avidin 
as a second step reagent. Three-color FACS  |  analysis was performed 
on the FACStar  pi'|  as described above. 
Results 
Presence o/c-kit + Thy-I t~ Lin-  Cells among Thymocytes and 
Bone Marrow Cells.  It is known that pluripotent hemato- 
poietic stem cells (HPSCs) in bone marrow express low levels 
of Thy-1 antigens and lack expression of surface markers that 
characterize  cells within defined differentiated hematolym- 
phoid call lineages (Thy-1  l~ and Lin-) (2, 24). Our previous 
studies (9) have shown that pluripotent stem cells express 
high amount of c-kit molecules. We first tested thymocytes 
for the expression of c-kit. Four-color FACS  |  analysis with 
CD4 (PE), CD8 (FITC), Thy-1 (TK), and c-kit (APC) anti- 
bodies was performed with thymocytes from 6-wk-old B6-Ly 
5.1 mice. Thymic cells expressing c-kit were not visible on 
a usual contour plot when total thymic population was ana- 
lyzed without gating. However, when gates were set so that 
only the c-kit and Thy-1 expressions of CD4-CD8-  thymo- 
cytes were examined, cells expressing c-kit were clearly de- 
tectable (Fig.  1). These cells are c-kit + Thy-1  l~ but negative 
for Gr-1, Mac-l, B220, and TER119 (data not shown), just 
as c-kit-positive  hematopoietic stem cells in bone marrow 
(9).  We assumed that c-kit-positive  cells in thymus were 
PHSCs from bone marrow colonized in adult thymus, and 
the following experiments were performed to test this hy- 
pothesis. 
Compared Stem Cell Activity of BM c-kit and Thymus c-kit. 
Fig. 2 demonstrates a staining profile of c-kit,  Thy-1, and 
lineage markers among thymocytes and bone marrow cells. 
There exist a population of cells that are c-kit + Thy-1  lo Lin- 
both in the bone marrow (BM c-kit calls) and in the thymus 
(thymus c-kit ceils). Approximately 0.5  _+  0.2%  of bone 
marrow cells and 0.07  +_  0.03% of thymocytes are found 
to be in this population. To determine whether they pos- 
sessed stem ceU activities, in vitro (CFU-C, HPP-CFC) and 
in vivo spleen colony assays (CFU-S) of sorted BM c-kit and 
thymus c-kit cells were performed. The results are summa- 
rized in Table 1. When 10  s of unfractionated BM cells were 
injected into lethally irradiated mice, 13.2 _+ 1.3 colonies were 
observed on day 10. Although both of them are phenotypi- 
cally identical, injection of thymus c-kit cells produced no 
spleen colonies out of 104 cells, whereas 1,000 sorted BM 
c-kit cells formed 11.6  _+  0.8 colonies. 
In CFU-C assay, sorted BM c-kit calls formed 43  _+  4.5 
colonies per 200 cells in the presence of IL-3 and EPO. Formed 
colonies were granulocyte-macrophage colonies,  erythroid 
bursts, and mixed colonies.  Thus, approximately one fifth 
of BM c-kit formed colonies, which provided an approximately 
35-fold enrichment of CFU-C. On the other hand, sorted 
thymus c-kit cells formed colonies only at a frequency of 
1/2,500 in CFU-C assay. 
Since these cells express c-kit,  we added its ligand, stem 
ceil factor, along with IL-1, IL-3, M-CSF,  and GM-CSF in 
the medium for in vitro colony assay. This type of CFU-C 
(HPP-CFU) assay is known to detect the earliest hematopoi- 
etic stem cells (25, 26). 200 sorted BM c-kit formed 25.7 _+ 
0.7 colonies, whereas neither 107 unfractionated thymocytes 
nor 104 sorted thymus c-kit cells formed colonies. 
The data indicated that, in contrast to BM c-kit, thymus 
c-kit does not have potential to differentiate into erythroid/ 
myeloid lineages.  It is suggested that thymus c-kit are the 
lymphocytes progenitor cells that the calls have already lost 
their multipotency. 
Intra-thymic Injection of BM c-kit and Thymus c-kit Cells.  De- 
spite the fact that thymus c-kit cells were shown to contain 
a small number of CFU, ceils in this population may still 
constitute the earliest T precursors in the adult mouse thymus. 
To investigate the potential of BM and thymus c-kit cells to 
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Figure  1.  The expression  ofc-k/t 
on Thy-11~  CD4CD8 double nega- 
tive thymocytes. Total thymocytes 
obtained from 6-wk-old B6-Ly 5.1 
mouse  were  stained with  APC- 
conjugated c-kit, biotinylated  Thy-1, 
PE-conjugated Gkl.5,  FITC-con- 
jugated Ly 2 rat mAbs. Biotinyhted 
antibody  was  visualized  by 
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second step reagent. The expression 
of c-kit  and  Thy-1 in  CD4CD8 
double negative cells was presented 
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Figure 2.  c-kit + Thy-11~  Lin- 
cells in adult murine thymus and 
bone marrow. Both thymocytes  and 
bone marrow  cells  were  depleted  of 
cells bearing lineage markers (Lin 
markers-Biotin cocktail:  B220, 
Mac-l, Gr-1, TER119, CD4, and 
CD8) by immunomagnetic beads 
treatment. The depleted  population 
was stained  in three  colors  with an- 
tibodies against c-kit (APC), Thy-1 
(FITC), and Streptavidin-PE  second 
step reagent. Gate  was set for Thy- 
11~  cells (/eft) and c-kit/Lin expres- 
sion of the gated Thy-1  lo cells was 
shown (right). 
differentiate into the T cell lineage, we performed organ cul- 
tures of fetal thymic lobes microinjected with various sorted 
cell populations (20). Thus, -500-1,000 BM or Thymus c-kit 
cells sorted from B6-Ly 5.1 mice were injected into deoxy- 
guanosine-treated  thymic lobes  (approximately 20  lobes/ 
group) of day 14 B6-Ly 5.2 fetus. Fig. 3 shows the changes 
with time of CD4/CD8 expression of the donor type (LyS.1) 
thymocytes. It is evident that both BM and thymus c-kit cells 
were capable of differentiating into T cells in the fetal thymic 
microenvironment. At first, the cells proliferated in CD4CD8 
double negative stage.  And  then,  they differentiated into 
CD4CD8 double positive stage via CD8 single positive im- 
mature stage as in normal thymocyte development (5, 27, 28). 
Of note is the appearance of CD4 single-positive cells from 
BM c-kit but not from thymus c-kit cells at day 20. These 
cells are CD4 + CD8-  but TCR-  immature T  cells  (data 
not  shown).  This may suggest  that  BM c-kit  includes  T 
precursor cells that differentiate into CD4CD8 double posi- 
tive cells via CD4 single positive transitional stage (29). Al- 
ternatively, these cells may become CD4 +  CDS- TCR + ma- 
ture T  cells by simple upregulation of the TCR (30). 
As shown from the results of three independent experi- 
ments, both BM and thymus c-kit  cells differentiated into 
T cells in organ culture (Fig. 4 A). However, CD4CD8 double 
positive thymocytes differentiated 3-4-d later out of BM c-kit 
cells than out of thymus c-kit cells (Fig. 4 B). This difference 
Table  1.  Colony  Formation  by BM and  Thymus  c-kit Cells 
Number of  Number of  Number of 
Cells sorted from  CFU-C*  CFU-S*  HPP-CFCS 
Total BM cells  63.0  -+  12  /104  13.2  _+  1.3  /103  ND 
Total thymocytes  7.0  _+  2.8  /107  1.8  _+ 0.6  /107  0  .+  0  /107 
BM c-kit  43.0  +  4.5  /200  11.6  _+  0.8  /103  25.7  +  0.7  /200 
Thymus c-kit  4.0  +_ 0  /104  0  +_  0  /104  0  +_  0  /104 
The c-kit+ Thy-llo  Lin- cells  from  both bone marrow and thymus were sorted on the basis of staining analysis (Fig. 2). Stem cell assays were per- 
formed with both fractions and unfractionated bone marrow cells and thymocytes. 
* Numbers of colonies in the presence of IL-3 and EPO at day 14. 
* Cells were injected into irradiated B6 mice intravenously  and the number of spleen colonies were counted at day 10. 
S Number of colonies in the presence of IL-1, IL-3, M-CSF, GM-CSF, and SCF(KL) at day 14. Mean +_ SD for quadruplicates. 
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Figure 3.  Thymic reconstitution  by thymus c-kit and BM c-kit cells. 500-1,000 purified thymus c-kit or BM c-kit cells were injected into dGuo-treated 
fetal thymic lobes by using micro manipulator  under the microscope.  After the days indicated, the T cell development  in donor-derived  cells in the 
repopulated tbyrnic  lobes (pooled) were revealed  in four-color  FACS  |  analysis with FITC-conjugated  anti-donor type Ly 5 (Ly 5.1), PE-conjugated 
anti-GK1.5 (CD4), and APC-conjugated  anti-Ly  2 (CD8). The expression  of CD4 and CD8 on Ly 5.1-positive  cells at each  time point by either  thymus 
c-kit (top) or BM c-kit (bottom) is shown. 
in the time course of T cell differentiation of BM c-kit cells 
was confirmed by injection of sorted populations into adult 
mice thymuses. The results were shown in Fig. 5 and sum- 
marized in Fig. 4 C. Both BM c-kit cells and thymus c-kit 
cells responded to thymic microenvironment but thymus c-kit 
cells differentiated into T cells earlier than BM c-kit cells did, 
as in the f~tal thymus. The maximum proportions of CD4CD8 
double positive cells were reached at day 16 when using thymus 
c-kit cells and about day 20 when using BM c-kit cells. These 
data suggest that thymus c-kit cells are more advanced in the 
T  cell differentiation pathway than BM-c-kit cells. 
Blocking Assay by Using c-kit Antibody.  To investigate a 
possible functional role of c-kit molecule in the early T cell 
differentiation process, the micro organ culture of BM c-kit 
cells and thymus c-kit cells was performed by using blocking 
type antibody ACK-2 (anti-c-kit mAb) (7). As shown in Fig. 
6, addition of anti-c-kit antibody to the culture medium at 
time zero of the organ culture did not change the growth 
and differentiation of thymocytes from thymus c-kit cells, but 
completely blocked growth and differentiation from BM c-kit 
ceils. 
As discussed above, we assumed that BM c-kit shifted for 
thymus c-kit during first 4 d, and thus, we speculated that 
c-kit is required in this duration. To prove this hypothesis, 
the antibody was added at day 4 of the culture of thymi in- 
jected with BM c-kit cells, its effect was less significant and 
the cells caught up their growth and differentiation. These 
data suggest that some function associated with c-kit is re- 
quired at least some time during the first 4 d ofT cell differen- 
tiation from BM c-kit cells, and that thymus c-kit cells have 
already passed  this c-k/t-dependent differentiation stage. 
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Lymphoid and NK Cells Restricted Differentiation Capacity 
of Thymus c-kit Cells.  To define further the developmental 
potential of the thymus c-kit calls, the system of intravenous 
transfer into mice differing at the Ly 5 locus was used (31). 
We analyzed ceils in the spleen and thymus 3 wk after transfer. 
The reconstitution was analyzed by comparing donor-derived 
(Ly 5.2) cells with recipient-derived (Ly 5.1) cells. In the re- 
cipient mice, the level of reconstitution by the thymus c-kit 
cells was 0.64 _+ 0.46% in spleen and 0.44  _+ 0.81 in thymus. 
These results were much lower than those of BM c-kit cells, 
since injection of 104 BM c-kit cells usually resulted in more 
than 95% reconstitution by the donor type cells (data not 
shown). 
As we expected, thymus c-kit cells differentiated into T 
cells but not into myeloid lineage cells. However, we could 
also find reconstitution of B and NK cells (Fig. 7) after intra- 
venous injection of thymus c-kit cells. In contrast, not many 
lymphoid cells of the recipient type had yet appeared. 
Discussion 
FACS  |  multi-color analysis unambiguously revealed the 
presence of c-kit-positive cells in the thymus. These cells, that 
correspond to 0.05%. of total thymocytes, are Thy-11~ and 
are negative for lineage markers. We named them thymus 
c-kit. On these grounds, they are phenotypically similar to 
the previously defined pluripotent hematopoietic stem cells 
in the bone marrow (BM c-kit cells). 
However,  the two  cell types appear  to be functionally 
different and thymus c-kit cells cannot be considered as mere 
BM c-kit cells having migrated from the bone marrow into C 
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Thymic reconstitution by the BM c-kit or thymus c-kit cells 
A 
in the dGuo-treated fetal thymic lobes or irradiated adult thymus. After 
the times indicated, the relative level  of donor-derived  cells  and the expres- 
sion of CD4 and CD8 of donor-derived cells  in the recipient thymus were 
revealed by the same staining procedure as in Fig. 3. At each time point, 
the data represented  are the mean values  of three independent experiments 
with BM c-kit (m) and thymus c-kit (O). (,4) Overall reconstitution at 
each time point by the BM or thymus c-kit cells, given by the percent 
of donor-type Ly 5.1 + cells in the recipient fetal thymic lobes. (B) Ki- 
netics of donor-derived  CD4CD8 double  positive  cells  in fetal thymic lobes 
after injection of  BM or thymus c-kit cells. (C) Kinetics  of  CD4CD8 double 
positive cells in adult thymus after injection of BM or thymus c-kit cells. 
the thymus. Indeed, unlike BM c-kit cells, thymus c-kit cells 
cannot form myeloid or erythroid colonies either in vivo or 
in vitro although  they have retained the ability to differen- 
tiate into cells of the lymphoid lineage.  Our data therefore 
strongly suggest that thymus c-kit cells represent committed 
lymphoid progenitors whereas BM c-kit cells are more primi- 
tive hematopoietic precursors and include pluripotent  stem 
cells. 
In in vivo and in vitro kinetic studies, both BM c-kit cells 
and thymus c-kit cells proliferated vigorously into CD4CD8 
double negative cells, followed by the appearance of CD4CD8 
double positive cells. Interestingly,  double positive cells always 
appeared 3-4 d earlier from thymus c-kit than from BM c-kit 
cells.  These data support the notion  that  thymus c-kit  cell 
type is a lymphoid committed progenitor whose transition 
from BM c-kit cells takes 3-4 d. Where and how this transi- 
tion is made is still questionable. Thymus c-kit cells may be 
produced in the bone marrow. In this respect, although the 
anti-c-kit antibody nearly completely blocks the proliferation 
of BM c-kit  cells,  few cells develop into CD4CD8  double 
positive thymocytes in the treated thymic lobes. These thymo- 
cytes are presumably derived from lymphoid progenitors resis- 
tant to the antibody, a conclusion that could be taken as in- 
dicative of the presence of a very small number  of T  cell 
precursors in the bone marrow, whose differentiation stage 
is equivalent to that of thymus c-kit cells, and would eventu- 
ally later migrate to the thymus. But thymus c-kit cells may 
also be produced in the thymus from migrating  BM c-kit 
cells. The fact that BM c-kit cells injected in the thymus de- 
veloped into T cells clearly indicates that this process can occur 
in the thymus itself. If BM c-kit migrates into the thymus, 
one expects to find pluripotent  hematopoietic stem cells in 
the organ. Although we could not detect in the thymus cells 
capable of forming CFU-S or HPP-CFC, the possibility that 
some BM c-kit cells and not the T-committed progenitors, 
come to the thymus and act as a source of T  lymphocyte. 
Given that a bone marrow stem cell has a large proliferative 
capacity, only a few ceils each a month are necessary to sus- 
tain T  lymphocyte proliferation in the thymus (32).  These 
few ceils could not be detected as such.  We presently favor 
the hypothesis according to which some bone marrow stem 
cells,  rather than T-committed progenitors,  migrate to the 
thymus  and differentiate there into T  cells. 
Irrespective of the place they are formed, are thymus c-kit 
cells the earliest T cell progenitors in the thymus? According 
to Wu et al. (6, 33), the earliest precursor cells in the adult 
mouse thymus are CD4 dull positive cells. We have therefore 
analyzed the surface phenotype of thymus c-kit cells using 
four-color FACS  |  analysis.  We could identify the presence 
of CD4  ~ thymocytes among the thymic c-kit-positive  popu- 
lation.  However, as far as we carefully studied, majority of 
thymus c-kit ceils that we used in our experiments did not 
express CD4. Judging from the experimental procedure used 
by Wu et al., (6, 33) it is likely that the cell population they 
studied included the thymus c-kit cells we describe here. Thus, 
the characteristics of the CD4  I~ precursor cells they reported 
could have been at least in part those of thymus c-kit cells. 
Precise developmental relationship between thymus c-kit cells 
and "low CD4 precursor" remains to be determined. In our 
opinion,  thymus c-kit cells are derived from BM c-kit cells 
and the CD41~ lymphoid progenitors found by Wu et al. in 
the thymus could derive either from Lin-  Thy-1 l~ Sca-1 + 
(2) or from Lin-  Thy-11~ c-kit + (9) stem cells. Alternatively, 
low CD4 precursors may be derived from the CD4  l~ hema- 
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Figure  5.  Thymic reconstitution of Thymus c-kit (top), or BM c-kit (bottom).  104 sorted thymus c-kit or BM c-kit cells were intra-thymically in- 
jected into irradiated (6.5 Gy) recipient mice.  After the times indicated, the kinetics of CD4CD8  expression  on donor-derived cells were analyzed 
by the same staining procedure in Fig. 3. 
topoietic stem cells in the bone marrow that we and others 
have reported (34-36)  and which appear to be independent 
of the Lin- Thy-11~  stem cells. More precise analysis using 
multi-parameter cell sorting and organ culture, preferably at 
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Figure 6.  Effect of c-kit antibody (ACK-2) on thymic reconstitution 
of BM c-kit and thymus c-kit cells. 500-1,000  sorted BM c-kit or thymus 
c-kit cells were injected into dGuo-treated fetal thymic lobes. After the 
days indicated, the T cell development in donor-derived  cells in the repopu- 
late(] thymic lobes were revealed in FACS  |  analysis. Percentage of donor 
derived cells in the lobes injected with thymus c-kit cells and cultured in 
the presence of 10 #g/ml of c-kit antibody (0), in the lobes injected with 
BM c-kit cells and cultured in the presence of 10 #g/mi of c-kit antibody 
(m), in the lobes injected with BM c-kit cells and c-kit antibody was added 
at day 4 of culture (A), in the lobes injected with thymus c-kit cells and 
cultured in the presence of 10 gg/ml of irrelevant  antibody (O), in the 
lobes injected with BM c-kit cells and cultured in the presence of irrelevant 
antibody (D). The data represented are the mean value and SD of three 
independent experiments. 
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a single cell level, should aid to clarify the chronological rela- 
tionships  among these cell populations. 
Molecular events that take place during these 3 d required 
for transition from BM c-kit to thymus c-kit are our main 
current focus of attention. A study on the role of c-kit during 
early T cell differentiation may constitute a due to the un- 
derlying molecular events. In this respect, the finding that 
the anti-c-kit antibody blocked T cell differentiation of BM 
c-kit cells but not that of thymus c-kit cells can be of  primary 
importance. Thymus c-kit cells may not be totally indepen- 
dent of c-kit, since recent report by Godfrey et al. (37) showed 
that c-kit + thymocytes proliferated in the presence of SCF 
and IL-7 and that this proliferation was blocked by the anti- 
c-kit antibody at higher concentration (50 gg/ml). How- 
ever, it is evident from our data that BM c-kit and thymus 
c-kit cells are different in terms of dependency on the c-kit- 
mediated signaling. Thymus c-kit cells have lost their capacity 
to differentiate into nonlymphoid  cells, whereas on the other 
hand, they have become less dependent on the c-kit-medi- 
ated signals. Thus, lymphoid committed progenitors would 
proliferate and differentiate under the control of other lineage- 
specific signals such as IL-2 or IL-7 (38-40) and may use c-kit 
in different way than BM c-kit. The function of c-kit in the 
T cell progenitor cells can be approached through the fact 
that the ligand for c-kit (KL) is expressed in fetal thymus 
(41). It is not known whether KL expressed in the thymus 
is membrane bound, soluble, or sequestered. If the membrane- 
bound form of KL is expressed on epithelial or stromal cells 
of the thymus, c-kit may play a role as a kind of adhesion 
molecule ensuring the migration to the proper micro envi- 
ronment within the thymus. 
Lastly, we showed that thymus c-kit cells had a potential 
to differentiate into NKI.1 + cells upon intravenous  injec- 
tion. The developmental origin of NK cells and the relation- 
ship between T celt and NK cell precursors have been con- le.  ,  .1~  ,  .  IM,  IJ~,  .  PM,.  lain,  I  m.  ,  .  14~  ,  .  I~.  ,.  ItS,  .  I~,,  I~m,  .  I  .  10.  ,  .  14e.  ,  .  lU,  It~,  .  ItS,  .  I~m,  .  [ 
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Figure 7.  Analysis  of hemopoietic lineage reconstitution in spleen by the thymus c-kit cells. 104 sorted thymus c-kit cells were intravenously  injected 
into irradiated mice. 3 wk after injection, the recipient spleen and thymus were analyzed for donor-derived cells by use of three-color flow cytometry 
with biotinylated anti-Ly 5.1 (donor type Ly 5), FITC-conjugated  lineage markers either anti-Gr-1, Mac-l, or NKI.1 and PE-conjugated  lineage markers 
either anti-B220, GK 1.5, or Ly 2 with APC-avidin as second step reagent. In this experiment, donor and host differed  in Ly 5 allotypes. After FACS  | 
analysis, gate was set so that the hematopoietic lineage reconstitution of recipient cells (A), and that of donor-derived  cells (B) were shown. The result 
presented is representative of a series of similar experiments. 
troversial. Some investigators have supported an assignment 
of NK cells to the myeloid or the monocytic lineage (42, 
43). On the other hand, a recent report by Rodewald et al. 
(44) suggested the presence of a common T/NK precursor 
in  the  thymus.  Although  it requires a clonal assay system 
to draw a definite conclusion, our data support the idea that 
NK cells and  T  cells have a  common progenitor. 
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